Laboratory Network

The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health Organization's elimination targets. Performed on Roche’s industry-leading and widely available cobas immunoassay systems, the test enables laboratories to meet growing tuberculosis infection testing needs by reducing reliance on manual workflows through automation and digital solutions.

American Oncology Network (AON) and other community oncology providers launching now as part of a pilot program that provides access to Haystack MRD Secaucus, NJ /PRNewswire/ - Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced it is integrating its Haystack MRD® ctDNA test and Comprehensive Genomic Profiling services for solid tumor cancers within OncoEMR®, an electronic health record (EHR) from Flatiron Health, via a pilot program with...

Milan /PRNewswire/ - Tethis S.p.A., a pioneering life sciences and diagnostics company, today announces the strategic expansion of the commercial reach of its SmartBioSurface® slides through a network of international channel partner across Brazil, India, China and South Africa. This initiative broadens access to SmartBioSurface for laboratories working with challenging cellular samples in rapidly growing life science markets.

Most patients need hematology tests, and fast results help inform timely care decisions Laboratory workflows affect how quickly clinicians receive time-sensitive test results The hematology analyzer simplifies complex testing for consistency across varying staff expertise Siemens Healthineers now offers U.S. laboratories a comprehensive hematology solution that brings together automation, middleware, and remote digital slide review to help deliver time-sensitive patient results with greater...

Exclusive licensing agreement with Incite Genomics brings innovative pharmacogenomic platform to healthcare providers nationwide Newport, KY (GLOBE NEWSWIRE) - Ethos Laboratories today announced the national launch of CNSDose™, a pharmacogenomic testing platform that will be offered throughout the United States under an exclusive licensing agreement with Incite Genomics.

This is the first published application of data envelopment analysis to six major pharmaceutical analytical validation guidelines, including ICH Q2(R2), USP, ChP, and Brazil's ANVISA.

New MCP integration bridges diseases, medications, procedures, laboratory tests, outcomes, and eligibility criteria in plain language to automatically translate them into retrieval-ready code sets across clinical vocabularies directly into Databricks Marketplace Franklin, TN /PRNewswire/ - Kythera Labs, a data technology leader that enables higher fidelity in healthcare data for Health Provider and Life Sciences organizations and recipient of the 2026 Databricks ISV Innovation Built-On...

SBC becomes a testing facility for Donor Network West, serving more than 13 million people across Northern California and Northern Nevada. Stanford Blood Center (SBC) today announced the successful launch of its testing services, including infectious disease and immunohematology, for Organ Procurement Organizations and Tissue Banks, expanding its specialized laboratory services to support organ and tissue donations throughout Northern California and beyond.

Partnership with Hamburg Trading Corp to advance applied testing and life science research Serving as a learning hub to empower the next generation of Filipino scientists through hands-on access to molecular workflows Facility designed to remove logistical barriers for researchers, enabling on-site evaluation without the need for internal equipment clearances QIAGEN, a global provider of Sample to Insight solutions, has officially commenced a new distribution partnership with Hamburg Trading...

The Anti Asialo GM1 antiserum reacts with mouse and rat NK cells; mouse monocytes (liver cells which contain no NK cells; bone marrow; fetal liver cells; spleen cells of nude mice macrophages); fetal thymocytes (12 days old; ratio of existence decreased gradually until there were none in newborn mice). Preparation: Purified asialo GM1 from bovine brain tissue was repeatedly immunized with methylated bovine serum albumin and with complete Freund’s adjuvant.